Designing a phase‐III time‐to‐event clinical trial using a modified sample size formula and Poisson‐Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution
- 5 November 2023
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 42 (30) , 5694-5707
Abstract
A priori estimation of sample size and subject accrual in multi-site, time-to-event clinical trials is often challenging. Such trials are powered based on the number of events needed to detect a clinically significant difference. Sample size based on number of events relates to the expected duration of observation time for each subject. Temporal patterns in site initiation and subject enrollment ultimately affect when subjects can be accrued into the study. Lag times are common as the site start-up process optimizes, resulting in delays that may curtail observational follow-up and therefore undermine power. The proposed method introduces a Program Evaluation and Review Technique (PERT) model into the sample size estimation which accounts for the lag in site start-up. Additionally, a PERT model is introduced into a Poisson-Gamma subject accrual model to predict the quantity of study sites needed. The introduction of the PERT model provides greater flexibility in both a priori power assessment and planning the number of sites, as it specifically allows for the inclusion of anticipated delays in site start-up time. This model results in minimal power loss even when PERT distribution inputs are misspecified compared to the traditional assumption of simultaneous start-up for all sites. Together these updated formulations for sample size and subject accrual models offer an improved method for designing a multi-site time-to-event clinical trial that accounts for a flexible site start-up process.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (U01NS095869)
This publication has 18 references indexed in Scilit:
- Real-time prediction of clinical trial enrollment and event counts: A reviewContemporary Clinical Trials, 2015
- Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld FormulasJournal of Biopharmaceutical Statistics, 2015
- Prediction of accrual closure date in multi‐center clinical trials with discrete‐time Poisson process modelsPharmaceutical Statistics, 2012
- Predictive event modelling in multicenter clinical trials with waiting time to responsePharmaceutical Statistics, 2011
- Statistical Modeling of Clinical Trials (Recruitment and Randomization)Communications in Statistics - Theory and Methods, 2011
- Stochastic modeling and prediction for accrual in clinical trialsStatistics in Medicine, 2010
- Predicting accrual in clinical trials with Bayesian posterior predictive distributionsStatistics in Medicine, 2007
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1986
- Planning the size and duration of a clinical trial studying the time to some critical eventJournal of Chronic Diseases, 1974
- Application of a Technique for Research and Development Program EvaluationOperations Research, 1959